Riskpilot← Back to searchSign inGet full accessDeversify Health AB (publ)
ABBankruptOrg 5569710188Other non-specialised retail sale · NACE 4712Est. 20140 employees
Revenue 2023
SEK 200K
+852% vs 2022
EBITDA margin
-1685.5%
+52% vs 2022
Equity ratio
-19.3%
Financial strength
Net profit 2023
SEK -62,7M
-647% vs 2022
| Revenue | SEK 200K | +852% |
| EBITDA | SEK -3,4M | +52% |
| Net profit | SEK -62,7M | -647% |
| Total assets | SEK 5,8M | -91% |
| Equity | SEK -1,1M | -102% |
| Employees | 0 | — |
Legal name
Deversify Health AB (publ)
Org number
5569710188
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
8 maj 2014
Share capital
SEK 1 461 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av verkställande direktören avseende löpande förvaltningsåtgärder trots att styrelsen inte är behörig. Styrelsen ska bestå av 4 styrelseledamöter och 0 styrelsesuppleanter. Registrerad behörig styrelse saknas. Därför saknas också uppgift om firmateckningsrätten.
Company purpose
Bolagets verksamhetsföremål är att självt och genom dotter- och intressebolag utveckla, tillverka, marknadsföra och sälja varor, tjänster och utbildning inom området för hälsa och hälsovård och därtill hörande forskning och utveckling. Bolaget ska vidare tillhandahålla konsulttjänster avseende strategi, ledarskap, affärsutveckling och administration till dotter- och intressebolag, äga och förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 400 | 875 | 21 | 200 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −144 | −2 057 | −7 166 | −6 997 | −3 371 |
| Depreciation & amort. | −0 | −0 | −0 | −1 070 | −5 353 |
| EBIT | −144 | −2 057 | −7 166 | −8 067 | −8 724 |
| Net financials | — | −8 218 | −4 | −341 | −54 003 |
| Profit before tax | −144 | −10 276 | −7 170 | −8 392 | −62 727 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −144 | −10 276 | −7 170 | −8 392 | −62 727 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 66 | 16 329 | 63 716 | 66 361 | 5 819 |
| Equity | 526 | 15 867 | 59 152 | 60 893 | −1 124 |
| Long-term debt | 0 | 0 | 0 | 0 | 722 |
| Short-term debt | 366 | 462 | 4 564 | 5 468 | 6 220 |
| Total debt | 366 | 462 | 4 564 | 5 468 | 6 942 |
EBITDA margin
-1685.5%
This company
15.8%
Market median
-10768% vs market
20192023
Equity ratio
-19.3%
This company
38.2%
Market median
-151% vs market
20192023
Return on equity
-6272700000.0%
This company
18.4%
Market median
-34090760970% vs market
20192023
Net profit margin
-31363.5%
This company
8.1%
Market median
-387304% vs market
20192023
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20192023
Debt / equity
6.18×
This company
0.62×
Market median
-897% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JL Chief Auditor | Chief Auditor | 2021 |
AS Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (2) | ||
FG Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
AL Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Former (9) | ||
| Chairman | 2022 – 2024 | |
| Chairman | 2023 – 2023 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2023 – 2023 | |
| Chairman | 2020 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2020 – 2024 | |
| Deputy Board Member | 2020 – 2020 | |
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Deversify Health AB (publ) (this company)
Afrieuro Digital Ventures LimitedAFRIEURO DIGITAL VENTURES LIMITEDBoard members of Deversify Health AB (publ) also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Filip Gustaf Algot Ebbersten | Chief Executive Officer | 0 companies |
| Joakim Lindberg | Chief Auditor | 0 companies |
| Anders Svante Murman | Chief Executive Officer | 0 companies |
| Anna Lotta Tjulin Thörnqvist | Chief Executive Officer | 0 companies |
| Åsa Victoria Lang | Board of Directors | 0 companies |
| Olof Peter Persson | Chairman | 0 companies |
| Johan Nordin | Chairman | 0 companies |
| Fredrik Petter Holmström | Board of Directors | 0 companies |
| Sven Anders Robert Carlén | Board of Directors | 0 companies |
| Carl Johan Wilhelm Willdeck | Chairman | 0 companies |
| Peter Christian Hjorth | Chairman | 0 companies |
| Björn Sven Kåge Jonsson | Board of Directors | 0 companies |
| Emelie Sara Louise Smidt | Board of Directors | 0 companies |
| Clas Åke Peter Åkerström | Deputy Board Member | 0 companies |
| Josefine E K A Hamilton | Board of Directors | 0 companies |